Skip to main content
. 2019 May 29;2019:6708645. doi: 10.1155/2019/6708645

Figure 8.

Figure 8

Changes of DNA binding activity of NF-κB p65 in the lung. (a) The competition assay. The wild-type consensus oligonucleotide was added as a competitor for NFκB binding in order to monitor the specificity of the assay, and the mutated consensus oligonucleotide had no effect on NF-κB binding (n = 3). (b) Changes of DNA binding activity of NF-κB p65 in the lung (n = 6). The values are expressed as the means ± SE. AAP < 0.01 versus the normal group; BBP < 0.01 versus the model group; CP < 0.05 versus the APL group.